06:47 EST Lilly says Zepbound superior to Novo’s Wegovy weight loss in head-to-head trial
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Truist biopharma analyst to hold an analyst/industry conference call
- S&P 500 Slips after October’s Jobs Report
- Eli Lilly downgraded to Hold from Buy at Erste Group
- RBC sees little cause for concern over CMS’ proposed part D GLP-1 coverage rule
- Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz